Terms: = Uterine cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Prognosis
16 results:
1. Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-ezh2 interaction and enhances the efficacy of tazemetostat in endometrial cancer.
Chen L; Zheng X; Liu W; Sun Y; Zhao S; Tian L; Tian W; Xue F; Kang C; Wang Y
Cancer Lett; 2023 Dec; 578():216445. PubMed ID: 37866545
[TBL] [Abstract] [Full Text] [Related]
2. Bioinformatic Analysis of miR-200b/429 and Hub Gene Network in Cervical cancer.
Shukla V; Mallya S; Adiga D; Sriharikrishnaa S; Chakrabarty S; Kabekkodu SP
Biochem Genet; 2023 Oct; 61(5):1898-1916. PubMed ID: 36879084
[TBL] [Abstract] [Full Text] [Related]
3. Sodium Valproate Modulates the Methylation Status of Lysine Residues 4, 9 and 27 in Histone H3 of HeLa Cells.
Rocha MA; de Campos Vidal B; Mello MLS
Curr Mol Pharmacol; 2023; 16(2):197-210. PubMed ID: 35297358
[TBL] [Abstract] [Full Text] [Related]
4. CircAGFG1 aggravates the progression of cervical cancer by downregulating p53.
Wang XH; Li J
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1704-1711. PubMed ID: 32141537
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of enhance of Zeste homolog 2 (ezh2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Krill L; Deng W; Eskander R; Mutch D; Zweizig S; Hoang B; Ioffe O; Randall L; Lankes H; Miller DS; Birrer M
Gynecol Oncol; 2020 Feb; 156(2):423-429. PubMed ID: 31843273
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA LINC01535 promotes cervical cancer progression via targeting the miR-214/ezh2 feedback loop.
Song H; Liu Y; Jin X; Liu Y; Yang Y; Li L; Wang X; Li G
J Cell Mol Med; 2019 Sep; 23(9):6098-6111. PubMed ID: 31273925
[TBL] [Abstract] [Full Text] [Related]
7. Oncogenic histone methyltransferase ezh2: A novel prognostic marker with therapeutic potential in endometrial cancer.
Oki S; Sone K; Oda K; Hamamoto R; Ikemura M; Maeda D; Takeuchi M; Tanikawa M; Mori-Uchino M; Nagasaka K; Miyasaka A; Kashiyama T; Ikeda Y; Arimoto T; Kuramoto H; Wada-Hiraike O; Kawana K; Fukayama M; Osuga Y; Fujii T
Oncotarget; 2017 Jun; 8(25):40402-40411. PubMed ID: 28418882
[TBL] [Abstract] [Full Text] [Related]
8. High-Level Expression of RIPK4 and ezh2 Contributes to Lymph Node Metastasis and Predicts Favorable prognosis in Patients With Cervical cancer.
Azizmohammadi S; Azizmohammadi S; Safari A; Kaghazian M; Sadrkhanlo M; Behnod V; Seifoleslami M
Oncol Res; 2017 Apr; 25(4):495-501. PubMed ID: 27697098
[TBL] [Abstract] [Full Text] [Related]
9. Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix.
Zhang HM; Chen SQ; Yao SZ
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323178
[TBL] [Abstract] [Full Text] [Related]
10. Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b.
Zhang S; Zhang G; Liu J
APMIS; 2016 Aug; 124(8):649-58. PubMed ID: 27272214
[TBL] [Abstract] [Full Text] [Related]
11. LncRNAs: key players and novel insights into cervical cancer.
Peng L; Yuan X; Jiang B; Tang Z; Li GC
Tumour Biol; 2016 Mar; 37(3):2779-88. PubMed ID: 26715267
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical significance of expression of enhancer of zeste homolog 2 and 53 in cervical squamous cell carcinoma and intraepithelial neoplasia].
Zhang H; Chen S; Niu G; Jiang H; Yao S
Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):597-601. PubMed ID: 25430026
[TBL] [Abstract] [Full Text] [Related]
13. Analyzing simultaneous positive expression of ezh2 and P53 protein to improve predictive value in cervical squamous cell carcinoma.
Chen SQ; Zhang HM; Li JB; Jiang HY; Fan L; Kong LZ; Yao SZ
Int J Gynecol Cancer; 2014 Nov; 24(9):1653-8. PubMed ID: 25275664
[TBL] [Abstract] [Full Text] [Related]
14. Increased ezh2 expression is associated with proliferation and progression of cervical cancer and indicates a poor prognosis.
Liu Y; Liu T; Bao X; He M; Li L; Yang X
Int J Gynecol Pathol; 2014 May; 33(3):218-24. PubMed ID: 24681730
[TBL] [Abstract] [Full Text] [Related]
15. Lipocalin 2 expression is associated with aggressive features of endometrial cancer.
Mannelqvist M; Stefansson IM; Wik E; Kusonmano K; Raeder MB; Øyan AM; Kalland KH; Moses MA; Salvesen HB; Akslen LA
BMC Cancer; 2012 May; 12():169. PubMed ID: 22559235
[TBL] [Abstract] [Full Text] [Related]
16. ezh2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.
Bachmann IM; Halvorsen OJ; Collett K; Stefansson IM; Straume O; Haukaas SA; Salvesen HB; Otte AP; Akslen LA
J Clin Oncol; 2006 Jan; 24(2):268-73. PubMed ID: 16330673
[TBL] [Abstract] [Full Text] [Related]
